Compare USAS & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USAS | OMCL |
|---|---|---|
| Founded | 1998 | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Computer Manufacturing |
| Sector | Basic Materials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2004 | 2000 |
| Metric | USAS | OMCL |
|---|---|---|
| Price | $4.50 | $33.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $6.50 | ★ $55.83 |
| AVG Volume (30 Days) | ★ 3.5M | 501.2K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | $174.68 | $6.77 |
| Revenue Next Year | $53.17 | $5.22 |
| P/E Ratio | ★ N/A | $43.75 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $3.48 | $29.06 |
| 52 Week High | $10.50 | $51.84 |
| Indicator | USAS | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 46.18 |
| Support Level | $3.57 | $32.11 |
| Resistance Level | $6.35 | $35.61 |
| Average True Range (ATR) | 0.25 | 0.88 |
| MACD | -0.07 | 0.28 |
| Stochastic Oscillator | 2.98 | 89.17 |
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.